243 related articles for article (PubMed ID: 10706510)
1. Thrombotic risk factors in pulmonary hypertension.
Wolf M; Boyer-Neumann C; Parent F; Eschwege V; Jaillet H; Meyer D; Simonneau G
Eur Respir J; 2000 Feb; 15(2):395-9. PubMed ID: 10706510
[TBL] [Abstract][Full Text] [Related]
2. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
Wong CL; Szydlo R; Gibbs S; Laffan M
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):201-6. PubMed ID: 20182352
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for chronic thromboembolic pulmonary hypertension.
Bonderman D; Wilkens H; Wakounig S; Schäfers HJ; Jansa P; Lindner J; Simkova I; Martischnig AM; Dudczak J; Sadushi R; Skoro-Sajer N; Klepetko W; Lang IM
Eur Respir J; 2009 Feb; 33(2):325-31. PubMed ID: 18799507
[TBL] [Abstract][Full Text] [Related]
4. Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management.
Rosen K; Raanani E; Kogan A; Kenet G; Misgav M; Lubetsky A; Niznik S; Schäfers HJ; Segel MJ; Agmon-Levin N
J Heart Lung Transplant; 2022 Feb; 41(2):208-216. PubMed ID: 34836752
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors in chronic thromboembolic pulmonary hypertension].
Jiménez D; Gaudó J; Sueiro A
Arch Bronconeumol; 2009 Jun; 45 Suppl 6():11-4. PubMed ID: 20542195
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
Cheng CY; Zhang YX; Denas G; Du Y; Jing ZC; Pengo V
Intern Emerg Med; 2019 Jun; 14(4):521-527. PubMed ID: 30603858
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for chronic thromboembolic pulmonary hypertension.
Lang I; Kerr K
Proc Am Thorac Soc; 2006 Sep; 3(7):568-70. PubMed ID: 16963535
[TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis.
Manco-Johnson MJ; Nuss R; Key N; Moertel C; Jacobson L; Meech S; Weinberg A; Lefkowitz J
J Pediatr; 1996 Mar; 128(3):319-23. PubMed ID: 8774497
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
Barbui T; Finazzi G; Galli M
Ann Ital Med Int; 1997; 12(2):76-83. PubMed ID: 9333316
[TBL] [Abstract][Full Text] [Related]
10. Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension.
Ignatescu M; Kostner K; Zorn G; Kneussl M; Maurer G; Lang IM; Huber K
Thromb Haemost; 1998 Aug; 80(2):231-2. PubMed ID: 9716143
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension.
Bergin CJ; Hauschildt J; Rios G; Belezzuoli EV; Huynh T; Channick RN
AJR Am J Roentgenol; 1997 Jun; 168(6):1549-55. PubMed ID: 9168722
[TBL] [Abstract][Full Text] [Related]
12. Impact of high titre of antiphospholipid antibodies on postoperative outcome following pulmonary endarterectomy.
D'Armini AM; Totaro P; Nicolardi S; Morsolini M; Silvaggio G; Toscano F; Toscano M; Viganò M
Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):418-22. PubMed ID: 19934162
[TBL] [Abstract][Full Text] [Related]
13. The role of mononuclear cell tissue factor and inflammatory cytokines in patients with chronic thromboembolic pulmonary hypertension.
Yang M; Deng C; Wu D; Zhong Z; Lv X; Huang Z; Lian N; Liu K; Zhang Q
J Thromb Thrombolysis; 2016 Jul; 42(1):38-45. PubMed ID: 26667361
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
[TBL] [Abstract][Full Text] [Related]
15. Frequency of Thrombotic Risk Factors in Patients with Chronic Thromboembolic Pulmonary Hypertension and Acute Pulmonary Embolism: A Case-Control Study.
Dodson MW; Cirulis MM; Li H; Yue Z; Brown LM; Elliott CG
Clin Appl Thromb Hemost; 2022; 28():10760296211073277. PubMed ID: 35000431
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for chronic thromboembolic pulmonary hypertension.
Kim NH; Lang IM
Eur Respir Rev; 2012 Mar; 21(123):27-31. PubMed ID: 22379171
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism.
Guérin L; Couturaud F; Parent F; Revel MP; Gillaizeau F; Planquette B; Pontal D; Guégan M; Simonneau G; Meyer G; Sanchez O
Thromb Haemost; 2014 Sep; 112(3):598-605. PubMed ID: 24898545
[TBL] [Abstract][Full Text] [Related]
18. [The clinical characteristics of antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension].
Li C; Zhao JL; Liu S; Wang Q; Li MT; Zeng XF; Zhao Y
Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):198-201. PubMed ID: 30803178
[No Abstract] [Full Text] [Related]
19. Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension.
Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Nakanishi N
Chest; 2003 Oct; 124(4):1305-11. PubMed ID: 14555559
[TBL] [Abstract][Full Text] [Related]
20. Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk Factors.
Delcroix M; Kerr K; Fedullo P
Ann Am Thorac Soc; 2016 Jul; 13 Suppl 3():S201-6. PubMed ID: 27571001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
